Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ian Schofield

Edinburgh, U.K
Ian Schofield has been writing on issues affecting the pharmaceutical and biotech industry since the mid-1980s, specialising in EU and global policy and regulatory affairs.  As well as writing, editing and commissioning articles for Pharma Intelligence, Ian works for the Ask the Analyst service, providing tailor-made answers to questions posed directly by clients. He has a degree in modern languages from the University of Bath. Outside the realm of work, Ian plays guitar in a traditional music group and also enjoys a touch of cycling and gardening. He lives by the seaside about three miles from the centre of Edinburgh.

Latest From Ian Schofield

What The Pandemic Can Teach Us About Running Clinical Trials

Participants in a recent webinar looked at how the coronavirus is changing the way we look at clinical trials and whether new EU COVID-19 guidance might hold lessons for future approaches to study design.

Europe Clinical Trials

COVID-19: Global Agencies Step Up Focus On Real-World Data

There is much talk around the importance of clinical trials in finding new treatments and vaccines for COVID-19 patients, but observational studies in clinical practice also have a vital role to play, including the impact on pregnant women. 

Europe International

First Drug Approved Under New Scheme To Speed Access In Poorer Countries

Switzerland’s medicines agency has cleared Ferring’s carbetocin for preventing uterine haemorrhage under the Marketing Authorization for Global Health Products (MAGHP) procedure, which is intended to accelerate the approval of new products in low- and middle-income countries. 

Switzerland Middle East and Africa

Coronavirus Update: Big Trials, New Vaccine Platforms, And Fake Chloroquine In Africa

In addition to our daily in-depth coverage of key events relating to the coronavirus, we’re bringing you a periodic round-up of other pandemic developments. This edition covers events at the national and EU level. 

Europe Middle East and Africa

EU Court Clarifies Another SPC Conundrum

Can an SPC be awarded on the basis of a patent that does not give the actual name of the substance to be protected? A judgement from the EU's top court says it can, provided that a "skilled person" would be able to identify the substance from the functional claims in the patent.

Intellectual Property Legal Issues

EU Court Clarifies Another SPC Conundrum

Can an SPC be awarded on the basis of a patent that does not give the actual name of the substance to be protected? A judgement from the EU's top court says it can, provided that a "skilled person" would be able to identify the substance from the functional claims in the patent.  

Europe Legal Issues
See All
UsernamePublicRestriction

Register